Healthcare provider profile · identity verified

Mona L Brownfield, M.D.

Family Practice · BOONVILLE, MO · NPI 1023055605

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	615	158
Levothyroxine Sodium	Levothyroxine Sodium	521	108
Lisinopril	Lisinopril	484	109
Losartan Potassium	Losartan Potassium	409	97
Omeprazole	Omeprazole	383	91
Amlodipine Besylate	Amlodipine Besylate	368	101
Sertraline Hcl	Sertraline Hcl	283	61
Furosemide	Furosemide	241	41
Metformin Hcl	Metformin Hcl	235	58
Hydrochlorothiazide	Hydrochlorothiazide	218	57
Gabapentin	Gabapentin	205	46
Eliquis	Apixaban	193	26
Allopurinol	Allopurinol	174	40
Pantoprazole Sodium	Pantoprazole Sodium	174	42
Potassium Chloride	Potassium Chloride	169	33
Montelukast Sodium	Montelukast Sodium	168	34
Tramadol Hcl	Tramadol Hcl	160	26
Metoprolol Succinate	Metoprolol Succinate	157	38
Metoprolol Tartrate	Metoprolol Tartrate	139	34
Ozempic	Semaglutide	129	19
Rosuvastatin Calcium	Rosuvastatin Calcium	124	34
Duloxetine Hcl	Duloxetine Hcl	115	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	112	26
Alendronate Sodium	Alendronate Sodium	110	15
Mirtazapine	Mirtazapine	106	14
Trazodone Hcl	Trazodone Hcl	104	23
Albuterol Sulfate Hfa	Albuterol Sulfate	101	31
Escitalopram Oxalate	Escitalopram Oxalate	99	19
Simvastatin	Simvastatin	99	24
Fluticasone Propionate	Fluticasone Propionate	91	31
Tamsulosin Hcl	Tamsulosin Hcl	91	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	84	25
Celecoxib	Celecoxib	83	22
Citalopram Hbr	Citalopram Hydrobromide	83	20
Pregabalin	Pregabalin	81	11
Tizanidine Hcl	Tizanidine Hcl	77	23
Buspirone Hcl	Buspirone Hcl	76	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	14
Carvedilol	Carvedilol	72	18
Glipizide	Glipizide	71	20
Donepezil Hcl	Donepezil Hcl	70	suppressed
Mounjaro	Tirzepatide	70	11
Alprazolam	Alprazolam	69	11
Famotidine	Famotidine	66	15
Pravastatin Sodium	Pravastatin Sodium	63	14
Clopidogrel	Clopidogrel Bisulfate	62	20
Farxiga	Dapagliflozin Propanediol	61	suppressed
Propranolol Hcl	Propranolol Hcl	61	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	15
Xarelto	Rivaroxaban	58	11
Meloxicam	Meloxicam	56	17
Ropinirole Hcl	Ropinirole Hcl	55	14
Fluoxetine Hcl	Fluoxetine Hcl	54	11
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	53	53
Metformin Hcl Er	Metformin Hcl	52	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	suppressed
Finasteride	Finasteride	45	suppressed
Lovastatin	Lovastatin	45	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	45	suppressed
Januvia	Sitagliptin Phosphate	44	suppressed
Benazepril Hcl	Benazepril Hcl	43	suppressed
Prednisone	Prednisone	43	26
Spironolactone	Spironolactone	43	13
Bupropion Xl	Bupropion Hcl	41	11
Ondansetron Hcl	Ondansetron Hcl	41	13
Primidone	Primidone	38	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Ezetimibe	Ezetimibe	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	11
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Fenofibrate	Fenofibrate	33	suppressed
Ibuprofen	Ibuprofen	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	30
Arexvy	Rsvpref3 Antigen/As01e/Pf	32	32
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Lansoprazole	Lansoprazole	31	suppressed
Baclofen	Baclofen	30	13
Glipizide Er	Glipizide	30	suppressed
Myrbetriq	Mirabegron	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Estradiol	Estradiol	26	suppressed
Linzess	Linaclotide	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Atenolol	Atenolol	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	24	suppressed
Topiramate	Topiramate	23	suppressed
Digoxin	Digoxin	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	19
Torsemide	Torsemide	22	suppressed
Colchicine	Colchicine	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	15
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Nystatin	Nystatin	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Estradiol (Once Weekly)	Estradiol	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Cephalexin	Cephalexin	14	12
Chlorthalidone	Chlorthalidone	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Naproxen	Naproxen	14	suppressed
Azithromycin	Azithromycin	13	12
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Belbuca	Buprenorphine Hcl	12	suppressed
Buprenorphine	Buprenorphine	12	suppressed
Cartia Xt	Diltiazem Hcl	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Fosinopril Sodium	Fosinopril Sodium	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Lamictal	Lamotrigine	12	suppressed
Lithium Carbonate Er	Lithium Carbonate	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Synjardy	Empagliflozin/Metformin Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Cefdinir	Cefdinir	11	11
Clonidine Hcl	Clonidine Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Imipramine Hcl	Imipramine Hcl	11	suppressed
Lactulose	Lactulose	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error